The chemical class known as DOC2A Activators encompasses a diverse range of compounds that specifically target and modulate the activity of the DOC2A protein, a key player in neurotransmitter release and calcium-dependent exocytosis in neurons. DOC2A, or Double C2-like domains, alpha, is integral to the regulation of synaptic vesicle fusion and neurotransmitter release, interacting with calcium ions and SNARE proteins. Activators in this class are characterized by their ability to enhance or stimulate the functional activity of DOC2A, which may involve increasing its expression, stabilizing its structure, or augmenting its interaction with other proteins involved in exocytosis. The chemical structures of these activators can vary significantly, ranging from small organic molecules to larger, more complex compounds. Their mechanisms of action are equally diverse, potentially involving direct interaction with the DOC2A protein, influencing its transcriptional regulation, or altering its post-translational modifications.
The study of DOC2A activators is rooted in understanding the intricate mechanisms of synaptic transmission and neuronal communication. By influencing DOC2A activity, these activators can potentially affect the dynamics of neurotransmitter release, a process fundamental to neuronal signaling. This is particularly relevant in the context of synaptic plasticity, where the efficiency and modulation of neurotransmitter release are crucial for learning and memory. Research into DOC2A activators involves a multidisciplinary approach, incorporating insights from neurobiology, biochemistry, and pharmacology to identify and characterize compounds that interact with this protein. Such research not only contributes to a deeper understanding of the molecular underpinnings of synaptic transmission but also enhances the broader knowledge of neuronal function and plasticity. Investigating these activators offers a pathway to elucidate the complex dynamics of neurotransmitter release, a critical aspect of understanding brain function and the intricate network of neuronal communication.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Potassium Chloride | 7447-40-7 | sc-203207 sc-203207A sc-203207B sc-203207C | 500 g 2 kg 5 kg 10 kg | $25.00 $56.00 $104.00 $183.00 | 5 | |
May depolarize neurons, potentially increasing DOC2A expression in response to enhanced neuronal activity. | ||||||
N-Methyl-D-Aspartic acid (NMDA) | 6384-92-5 | sc-200458 sc-200458A | 50 mg 250 mg | $107.00 $362.00 | 2 | |
As an agonist of NMDA receptors, it could upregulate DOC2A expression by promoting calcium influx and neuronal activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, potentially increasing cAMP levels and influencing DOC2A expression through cAMP-dependent pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
A PKC activator that might modulate DOC2A expression through protein kinase C (PKC)-dependent signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Increases intracellular calcium, potentially upregulating DOC2A expression in response to altered calcium signaling. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Might influence DOC2A expression through its effects on signaling pathways involved in neuronal plasticity. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
By modulating neuronal activity and calcium signaling, caffeine could potentially influence DOC2A expression. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $42.00 $83.00 $155.00 | 7 | |
NO donors can affect neuronal signaling and might influence DOC2A expression through nitric oxide-mediated pathways. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $291.00 $566.00 | ||
As a major excitatory neurotransmitter, glutamate might upregulate DOC2A expression in response to increased synaptic activity. | ||||||
GABA | 56-12-2 | sc-203053 sc-203053A sc-203053B sc-203053C | 10 g 25 g 5 kg 10 kg | $63.00 $133.00 $450.00 $750.00 | 2 | |
Although primarily inhibitory, GABA might modulate DOC2A expression indirectly through its effects on neuronal networks. |